Drug firm Lupin on Wednesday said it has launched a product, used as an aid to smoking cessation treatment, in the U.S. market.
The company has launched Varenicline tablets in strengths of 0.5 mg and 1 mg, after having received approval from the U.S. Food and Drug Administration (USFDA), the Mumbai-based drug maker said in a regulatory filing.
The company's product is the generic equivalent of PF Prism CV's Chantix tablets, it added.
It is indicated for use as an aid to smoking cessation treatment.
ADVERTISEMENT
As per the IQVIA data, Varenicline tablets had estimated annual sales of $412 million in the US.
Shares of the company were trading 0.75% up at Rs 1,406.50 apiece on the BSE.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
Motoverse 2025: Royal Enfield's Popular Festival Is Back In Goa — Check Dates, Tickets
Aug 20, 2025
Goa: FIR Against Cabbie, Uber For ‘Illegal’ Operations At Mopa Airport
Aug 20, 2025
Indian Tablet PC Market Grows 20% In Q2 FY25; Apple Leads With 30% Share: Cybermedia
Aug 16, 2025
Prism Johnson Share Price Jumps Nearly 5% After Net Loss Drops 70% In Q1 FY26
Aug 07, 2025
POPULAR
1
Vaishno Devi Landslide: Adityanath Announces Rs 4 Lakh Ex Gratia For Victims From UP
2
UP Liquor Exports Set To Cross 1,000 Million Litres By 2026: Industry Body
3
IATA Proposes Higher Age Limit Of 67 Years For Pilots Operating Commercial Flights
4
Delhi Traders See US Tariff Hike As Temporary Setback, Urge Support For Exports
5